The owner’s first question about selling is rarely the price. It is whether the staff will find out. Then the patients, the prescriber down the hall, the landlord, the wholesaler rep, and the competitor two blocks away who would like nothing better than to hear the store is in play.
A pharmacy sale can be run so that none of them knows until the day you choose to tell them. Doing it requires a few habits from the first conversation to the last, and a document every buyer signs before they learn which pharmacy it is. This guide explains both, and ends with a template for that document.
Why it matters more for a pharmacy than for most businesses
Three reasons. Staff are the business: a pharmacist who leaves because they heard a rumour takes a licence, a relationship with patients and sometimes a prescriber relationship with them, and a buyer prices that risk. Patients can move their files in an afternoon, and a competitor who learns a store is for sale has a reason to encourage it. And the regulator, the landlord and the wholesaler each have a formal role in the change of ownership; told at the wrong time, each can slow the deal or change its terms.
A leak does not usually kill a sale. It changes the price, because the buyer now sees a business under stress, and it changes the seller’s position, because the seller now needs the deal to close.
How a confidential sale is run
The blind profile
The first thing a buyer sees is an anonymous profile: the province or region, the type of pharmacy, rounded revenue and earnings, prescription volume as a range, the lease situation in general terms, the staffing picture, and the features that make the opportunity worth a look. No name, no address, no photographs that identify the store, no figures precise enough to be matched to a known pharmacy. Our public listings are built this way, and each one is checked against that rule before it goes live.
Qualification before identification
A buyer who enquires is qualified before they learn which pharmacy it is: who they are, whether they are a pharmacist or working with one, whether they have bought before, and whether their financing is realistic. The qualification conversation is short, but it filters out the curious, the competitor and the buyer who could not close.
The NDA
A qualified buyer signs a non-disclosure agreement before receiving anything that identifies the pharmacy. The NDA is not a formality; it is the document that gives the seller recourse. What it needs to cover is set out below, and the template at the end of this guide is drafted for exactly this situation.
Staged disclosure
After the NDA, the buyer receives the Confidential Information Memorandum: the pharmacy’s identity, normalized financials, the lease summary, the staff picture and the story of the business. Detailed material (the lease itself, staff contracts, bank statements, supplier agreements) comes later, after a letter of intent is signed and due diligence begins, and usually through a data room that records who has seen what. Each stage exposes more, to fewer people, who are more committed.
Patient data
Before closing, patient data is aggregated and de identified only: prescription counts by month, payer mix, top prescriber shares measured from the dispensing system, days supply mix. A buyer does not need, and should not be given, anything that identifies a patient. Identifiable records transfer at closing under the privacy law that applies to the pharmacy, which is a legal transfer the lawyers handle, not a due diligence item.
Visits
Buyers want to see the store. Visits are scheduled outside opening hours, or the buyer comes as an ordinary customer and does not speak to staff. Meetings with the owner happen off site. Owners who need to be away for meetings keep the reason generic.
Who is told, and when
| Who | When | Why |
|---|---|---|
| Your accountant and lawyer | Before marketing | They prepare the normalized financials and review every document |
| The buyer | After NDA and qualification | One buyer at a time, in stages |
| The landlord | When consent to assign the lease or to a change of control is needed, usually during due diligence or at purchase agreement | Check the lease: some require earlier notice or give the landlord rights on a sale |
| The College | When the ownership change application is filed | Lead times: at least 30 days in BC for a change of direct owner, at least 45 days in Ontario, where a new Certificate of Accreditation is issued |
| The wholesaler and banner | When the buyer’s account and any banner agreement are being set up or assigned, usually after the purchase agreement | Some agreements require notice of a sale; read them first |
| Staff | Usually after the purchase agreement is signed and conditions are satisfied, shortly before closing; timing planned with your lawyer and the buyer | Employment law and any employment contracts set the minimum; the buyer usually wants to meet key staff before closing |
| Patients and prescribers | At or after closing, in a message both parties agree | Continuity of care is the message; the vendor’s transition period supports it |
Nothing here is legal advice. The order above is how the deals we work on usually run; the lease, the employment contracts and the province’s law set the rules in a given case.
What the NDA needs to say
The agreement a buyer signs before learning which pharmacy it is should cover:
- The parties. The seller (or PharmacyBroker.ca on the seller’s behalf, with the seller as beneficiary) and the buyer, including any corporation the buyer may use.
- What is confidential. Everything disclosed in connection with the possible purchase, in any form, including the fact that the pharmacy is for sale and the identity of the seller. Standard exclusions for information already public or already known to the buyer.
- Permitted use. Evaluating the purchase, and nothing else.
- Permitted recipients. The buyer’s lawyer, accountant, lender and named advisers, each told the information is confidential and bound to keep it so, with the buyer responsible for them.
- No contact. No contact with the pharmacy’s staff, patients, prescribers, landlord, wholesaler or banner about the pharmacy without the seller’s written consent.
- Non-solicitation. No hiring or soliciting the pharmacy’s staff, and no soliciting its patients or prescribers, for a stated period (two years is common in the agreements we see) whether or not the purchase proceeds.
- Return or destruction. All material returned or destroyed on request or when the buyer withdraws, with written confirmation.
- No obligation to sell. Signing creates no obligation on either side to proceed.
- Term. Two to five years from signing.
- Remedies. Acknowledgement that a breach causes harm that money alone may not repair, and that the seller may seek an injunction as well as damages.
- Governing law. The province where the pharmacy is located.
Patient information is not covered by the NDA because it is not disclosed before closing. The NDA governs business information.
Where confidentiality usually fails
The owner tells one person. A colleague, a supplier rep, a friend who owns a pharmacy. The pharmacy community in any city is small. If the sale is to stay confidential, the circle is the owner, the spouse, the accountant, the lawyer and the adviser running the sale.
A listing that identifies the store. A precise revenue figure, a photograph of the storefront, “next to the X medical clinic in Y”. Each is enough for a local pharmacist to name the store.
Buyers who are not qualified. A competitor can sign an NDA. Qualification before identification is the filter; the NDA is the backstop.
Staff who notice. New faces after hours, the owner away for meetings, a stock count on an unusual day. A plausible routine covers most of it; a plan for the day staff are told covers the rest.
Letting a buyer talk to the landlord early. A buyer who approaches the landlord before the seller is ready can lose the seller the lease terms, or the sale. The NDA’s no contact clause exists for this.
The template
The download is a non-disclosure agreement drafted for a prospective buyer of a Canadian pharmacy, with placeholders in square brackets and short notes on each clause. It covers the eleven points above.
Download the pharmacy sale NDA template (Word)
It is not legal advice, and PharmacyBroker.ca is not a law firm. Have your lawyer review it before it is used, and expect a buyer’s lawyer to ask for changes.
Every pharmacy we sell is marketed this way. If you want to know what your pharmacy is worth without anyone knowing you asked, the valuation calculator needs no contact details, and a conversation with us is confidential from the first call.